KT5823
Based on 14 publication(s) in Google Scholar
KT5823, a selective the cGMP-dependent protein kinase (PKG) inhibitor with an Ki value of 0.23 μM, it also inhibits PKA and PKC with Ki values of 10 μM and 4 μM, respectively. KT5823 is a Staurosporine-related protein kinase inhibitor, increases thyroid-stimulating hormone-induced (Na+/I- symporter) NIS expression, and iodide uptake in thyroid cells. KT5823 arrests cells after the G0/G1 boundary and causes increases in the levels of apoptotic DNA fragmentation.
For research use only. We do not sell to patients.
- Purity : 99.9%
- CAS No.: 126643-37-6
- Formula: C29H25N3O5
- Molecular Weight:495.53
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) KT5823
More- Adv Mater. 2025 Dec 24:e16181. [Abstract]
- Nat Aging. 2026 Jul;6(7):1395-1416.
- Cell Death Dis. 2023 Oct 16;14(10):682. [Abstract]
- Mater Today Bio. 2024 Aug 10:28:101180. [Abstract]
- World J Gastroenterol. 2025 Dec 14;31(46):111631. [Abstract]
- Biol Direct. 2025 Nov 27;20(1):113. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167786. [Abstract]
- J Neurochem. 2025 May;169(5):e70077. [Abstract]
- Transl Stroke Res. 2025 Jun;16(3):868-881. [Abstract]
- Drug Dev Res. 2024 May;85(3):e22192. [Abstract]
- J Virol. 2026 Feb 17;100(2):e0165625. [Abstract]
- J Biol Chem. 2026 Jan 23;302(3):111202. [Abstract]
- Microbiol Spectr. 2024 Apr 2;12(4):e0322023. [Abstract]
- Res Sq. 2024 Jul 15.
-
Cell Imaging/Staining
-
WB
-
Cell Proliferation/Viability Assay
-
Cell Proliferation/Viability Assay
-
RT-PCR
All Antibiotic Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
PKA 10 μM (Ki) |
PKC 4 μM (Ki) |
In Vitro
KT5823 (15 μM, 18 h) arrests HSF55 cells in the G0 or G1 phase of the cell cycle[3].
KT5823 (100 nM and 1 mM, 24 h) causes dose-dependent increases in apoptotic DNA fragmentation in unstressed HRE-H9 cells [3].
KT5823 (0.2-200 μM, 30 min) enhances 8-pCPT-cGMP (HY-137016)-induced VASP phosphorylation, but not inhibits the activation of PKA by Forskolin (HY-15371) in human platelets[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Human platelets
-
Concentration:0.2-200 μM
-
Incubation Time:30 min
-
Result:Enhanced 8-pCPT-cGMP-induced VASP phosphorylation in human platelets.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Aβ1-42-treated mice[4]
-
Dosage:2 nmol
-
Administration:i.c.v., a single dose for 14 days
-
Result:Significantly prevented the effects of Bay 60-7550 on step-down latency both 1 and 3 h after the training session in the Aβ1-42-treated mice.
Chemical Information
-
CAS No. 126643-37-6
-
Appearance Solid
-
Molecular Weight 495.53
-
Formula C29H25N3O5
-
Color White to off-white
-
SMILES
C[C@@]([C@@]1(OC)C(OC)=O)(O[C@](N2C3=C4C=CC=C3)([H])C1)N5C(C2=C4C6=C7CN(C)C6=O)=C7C8=C5C=CC=C8
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (14)
-
Journal Impact Factor
-
Most Recent
-
Adv Mater
A Dual-Action Nucleoside-Based Supramolecular Hydrogel Combats Periodontitis by Disrupting the Bacteria-Osteoclast Cascade. [Abstract]2025 Dec 24:e16181. PMID: 41441772
KT5823 purchased from MedChemExpress. Usage Cited in: Adv Mater. 2025 Dec 24:e16181. [Abstract]
KT5823 (5, 10 μM) augmented OC differentiation in RAW264.7 cells.
KT5823 purchased from MedChemExpress. Usage Cited in: Adv Mater. 2025 Dec 24:e16181. [Abstract]
KT5823 (5, 10 μM) decreased the protein expression of PKG1 and VBASP in OCs derived from bone marrow precursors.
-
-
Cell Death Dis
Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress. [Abstract]2023 Oct 16;14(10):682. PMID: 37845207 -
Mater Today Bio
A photothermal responsive system accelerating nitric oxide release to enhance bone repair by promoting osteogenesis and angiogenesis. [Abstract]2024 Aug 10:28:101180. PMID: 39221216
KT5823 purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2024 Aug 10:28:101180. [Abstract]
KT5823 (0, 0.5, 1, 1.5, 2 μM; 3 days) did not affect the viability or proliferative capacity of BMSCs and HUVECs.
KT5823 purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2024 Aug 10:28:101180. [Abstract]
KT5823 (2 μM; 3 days) significantly downregulated the mRNA expression levels of PKG in BMSCs and HUVECs.
KT5823 purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2024 Aug 10:28:101180. [Abstract]
KT5823 (2 μM; 3 days) attenuated the osteogenic promotion effect of NO-NP@ICG by decreasing the protein expression of COL1a1, BMP2 and RUNX2, which were induced by NO-NP@ICG in BMSCs.
-
World J Gastroenterol
IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression. [Abstract]2025 Dec 14;31(46):111631. PMID: 41479643
KT5823 purchased from MedChemExpress. Usage Cited in: World J Gastroenterol. 2025 Dec 14;31(46):111631. [Abstract]
KT5823 (0-100 μM) showed antiproliferative for HGC-27 cells.
-
Biol Direct
NAMPT modulates muscle fiber type transition in PAD myopathy via the cGMP-PKG signaling pathway. [Abstract]2025 Nov 27;20(1):113. PMID: 41310770 -
Biochim Biophys Acta Mol Basis Dis
Silencing RGS7 attenuates atrial fibrillation progression by activating the cGMP-PKG signaling pathway. [Abstract]2025 Jun;1871(5):167786. PMID: 40086518 -
J Neurochem
PKG-Mediated Phosphorylation of TOP2A Activates HDAC to Drive Photoreceptor Cell Death in rd1 Mouse Inherited Retinal Degeneration. [Abstract]2025 May;169(5):e70077. PMID: 40320856 -
Transl Stroke Res
HDAC9 Deficiency Upregulates cGMP-dependent Kinase II to Mitigate Neuronal Apoptosis in Ischemic Stroke. [Abstract]2025 Jun;16(3):868-881. PMID: 38940872 -
Drug Dev Res
Anti-NSCLC role of SCN4B by negative regulation of the cGMP-PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validation. [Abstract]2024 May;85(3):e22192. PMID: 38678552 -
J Virol
Seneca Valley virus 3C protease targets the Nrf2/HO-1 pathway to antagonize its antiviral activity. [Abstract]2026 Feb 17;100(2):e0165625. PMID: 41489372 -
J Biol Chem
Nitric oxide mediates ET-1-induced-inhibition of NPPB-sensitive Cl- currents in the early distal convoluted tubule of the mouse kidney. [Abstract]2026 Jan 23;302(3):111202. PMID: 41581878 -
Microbiol Spectr
Heme oxygenase-1 is an equid alphaherpesvirus 8 replication restriction host protein and suppresses viral replication via the PKCβ/ERK1/ERK2 and NO/cGMP/PKG pathway. [Abstract]2024 Apr 2;12(4):e0322023. PMID: 38441979 -
Solvent & Solubility
In Vitro:
DMSO : ≥ 20 mg/mL (40.36 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Purity & Documentation
-
Data Sheet (285 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Gadbois DM, et al. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8626-30. [Content Brief]
[2]. Wyatt TA, et al. KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res Commun Chem Pathol Pharmacol. 1991 Oct;74(1):3-14. [Content Brief]
[3]. Chan SL, et al. Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG. Mol Hum Reprod. 2003 Dec;9(12):775-83. [Content Brief]
[4]. Ruan L, et al. Phosphodiesterase-2 Inhibitor Bay 60-7550 Ameliorates Aβ-Induced Cognitive and Memory Impairment via Regulation of the HPA Axis. Front Cell Neurosci. 2019 Oct 2;13:432. [Content Brief]
[5]. Burkhardt M, et al. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem. 2000 Oct 27;275(43):33536-41. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0180 mL | 10.0902 mL | 20.1804 mL | 50.4510 mL |
| 5 mM | 0.4036 mL | 2.0180 mL | 4.0361 mL | 10.0902 mL | |
| 10 mM | 0.2018 mL | 1.0090 mL | 2.0180 mL | 5.0451 mL | |
| 15 mM | 0.1345 mL | 0.6727 mL | 1.3454 mL | 3.3634 mL | |
| 20 mM | 0.1009 mL | 0.5045 mL | 1.0090 mL | 2.5226 mL | |
| 25 mM | 0.0807 mL | 0.4036 mL | 0.8072 mL | 2.0180 mL | |
| 30 mM | 0.0673 mL | 0.3363 mL | 0.6727 mL | 1.6817 mL | |
| 40 mM | 0.0505 mL | 0.2523 mL | 0.5045 mL | 1.2613 mL |